Join Now

The voice of Utah’s life sciences community

Medical Devices

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

BioUtah is the common voice and flag bearer for Utah’s life sciences industry, comprised of medical devices, pharmaceuticals, diagnostics, laboratories, research facilities, and biotechnology of all types. BioUtah connects industry with government, academia, capital markets, media, and service providers. Together we form an ecosystem that fosters collaboration, promotes innovation, and delivers technology that saves lives.

Learn More

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

August 6, 2026
Strategic Transactions Advocacy Track (STAT)

STAT delivers U.S. Government Advocacy for Foreign Investment & Concession Projects

August 6, 2026
London Stock Exchange: Biggest Changes to AIM Rules in Two Decades

For more than 30 years, AIM has been Europe’s most successful growth market.

August 6, 2026
Receptor.AI, Sethera Plan to Create Closed-Loop Discovery, Optimization Workflow for Difficult Therapeutic Targets

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow.

August 6, 2026
Roche Advances AI-Derived Drug with Partner Recursion

The Recursion option follows several years of work building what Recursion calls “maps of biology.“

August 6, 2026
Ratio Therapeutics Closes $70M Series C Financing

Round brings total capital raised to over $240M.

August 6, 2026
Dash Bio Raises $30M Series A to Accelerate Drug Development Timelines

Funding Brings Total Raised to $47.5M as Demand Grows for Better Infrastructure to Support Biopharma

August 6, 2026
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test

Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in decentralized point-of-care settings.

August 6, 2026
Co-Diagnostics Raises Capital Through Warrant Inducement Ahead of FDA Review

A company still awaiting its first FDA clearance just structured a capital raise around the urgency of that wait. On July 30, 2026, Co-Diagnostics, Inc. entered into a warrant inducement agreement with existing warrant holders, convincing them to exercise warrants early in exchange for new warrants at revised terms. The transaction is straightforward on its […]

2025 Utah Life Sciences Award Recipients

Lifetime Achievement
Dr. Wes Sundquist

Innovation Impact
Nusano

Entrepreneur of the Year
Shawn Fojtik

Executive of the Year
Fred Lampropoulos

Friend of Industry
Dr. Taylor Randall

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors